Subscribe to Newsletter

Rob Coker Deputy Editor of The Medicine Maker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

Content by Rob Coker:

 Business & Regulation Standards & Regulation

Settling the PrEP Patent Disputes

| Rob Coker | 2 min read

With US courts consistently ruling in favor of the PrEP drug manufacture, the CDC and DHHS have had no choice but to be humble.
Business & Regulation Standards & Regulation

Regulatory Flexibility in the Event of A Pandemic

| Rob Coker | 3 min read

Summarizing the updated lessons learned by the European Medicines Agency following the COVID-19 pandemic.
Manufacture Advanced Medicine

Pharma Fiction

| Rob Coker | 2 min read

A look back at The Medicine Maker archive and the influence of science fiction in the industry and science.
Manufacture Advanced Medicine

FDA or EMA Novel Drug Approvals 2024: Anagrams Edition

| Rob Coker

So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?
Business & Regulation Standards & Regulation

EFPIA Calls For Clarity Over JCA Concerns

| Rob Coker | 2 min read

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.
Manufacture Small Molecules

Small World

| Rob Coker | 5 min read

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.
Business & Regulation Digital Technologies

AI and the Copyright Question for R&D

| Rob Coker | 2 min read

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.
Manufacture Technology and Equipment

The Innovation Awards 2024

| Rob Coker | 9 min read

Welcome to our annual celebration of the top development and manufacturing technologies released over the course of the year!
Discovery & Development Advanced Medicine

The Challenges of Perfusion Perfection

| Rob Coker

How a collaboration between different organizations aims to advance perfusion for cell and gene therapies.
Business & Regulation Trends & Forecasts

Analyzing Access: Novartis is the New Leader in the 2024 Access to Medicine Index

| Rob Coker

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker